Pharma Stocks
-
BullFrog AI (BFRG) surges 122% on new commercial agreement with top-5 global pharma
BullFrog AI Holdings, Inc. (BFRG) is up 122.4% today. Here is some analysis on what might have caused this price…
Read More » -
Will ACC.26 Obicetrapib Data on Kidney, Safety and Lipids Change NewAmsterdam Pharma’s (NAMS) Narrative?
NewAmsterdam Pharma announced it would present multiple Phase 3 and outcomes-related data sets for its oral CETP inhibitor obicetrapib at…
Read More » -
Sun Pharma Advanced Research Company Ltd Faces Bearish Mo…
Technical Momentum Shifts to Bearish Territory SPARC’s technical trend has transitioned from mildly bearish to outright bearish, reflecting increased selling…
Read More » -
A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum
Recent share performance and business snapshot InnoCare Pharma (SEHK:9969) has drawn investor attention after a 5.7% one day gain, adding…
Read More » -
Takeda Pharmaceutical TSE 4502 Valuation Check After Positive Zasocitinib Phase 3 Psoriasis Data
Takeda Pharmaceutical (TSE:4502) is back in focus after releasing new Phase 3 data for its investigational TYK2 inhibitor zasocitinib in…
Read More » -
A Steady Pharma Leader with Global Reach and Innovation Focus for North American
Sanofi S.A. (ISIN: FR0000127771), a leading global pharmaceutical company, offers diversified exposure to vaccines, specialty care, and consumer health. North…
Read More » -
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion
Merck & Co., Inc. (NYSE:MRK) is included in our list of the best stocks to buy for financial stability. Merck…
Read More » -
Is Ligand Pharmaceuticals (LGND) Still Attractive After Its 165.7% Three Year Share Price Surge
If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk…
Read More » -
Navigating Diverging Paths in Pharma Strength and Agriculture Challenges for Investo
Bayer AG (ISIN: DE000BAY0017) faces contrasting fortunes in its pharmaceutical and crop science divisions amid global pressures. North American investors…
Read More » -
2 Stocks I Plan to Hold for the Next 20 Years
Key Points One is a diversified healthcare giant with a vast product lineup and an impressive dividend program. The other…
Read More »